Wilmington Healthcare wins first client for new NHS transformation tracker
July 24, 2018 |
Product helps pharma identify opportunities and tailor solutions to a changing NHS
Healthcare intelligence provider Wilmington Healthcare has won its first client for an innovative new service that helps pharma keep abreast of change within local NHS organisations and better understand their strategic priorities. The Healthcare Transformation Tracker, which is a Key Account Management (KAM) tool, enables pharma to search lengthy NHS documents at the touch of a button to identify opportunities within specific regions and allocate resources appropriately.
The product, which is now being used by a top pharma company, helps industry follow NHS change within three critical categories – disease and therapy areas; infrastructure, such as NHS estates, finance and transport, and the NHS transformation agenda.
Searches can be conducted across NHS organisations, such as trusts and Clinical Commissioning Groups (CCGs), within a Sustainability and Transformation Partnership footprint. Documents that can be perused include STP plans, operating plans, commissioning plans and board meeting papers.
For example, by searching on the term ‘diabetes’, a client can find out what individual STPs and their constituent organisations are saying about it; how services are being redesigned for it in different geographical regions and what is happening to enable this change with regards to NHS infrastructure.
To ensure they are targeting the appropriate personnel within local NHS organisations, pharma can also use the tracker to keep abreast of structural changes. For example, it can find out if a specific group of CCGs has formally merged or is acting as a single entity.
The service replaces Wilmington Healthcare’s STP tracker, that was launched in 2016, and reflects the radical change that continues in the NHS as ten areas prepare to become Integrated Care Systems (ICSs).
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Accessing key influencers within the NHS is becoming increasingly difficult for pharma. When companies do secure meetings, they should have a sound grasp of what is happening within a specific locality and go armed with a tailored solution that meets clearly identified needs.
“The transformation tracker helps pharma operate in this strategic and highly targeted way by enabling it to quickly extract relevant snippets of information from lengthy strategic documents and follow changes within the NHS as they unfold in different ways across different parts of the country.”
Ends
Notes to Editors
For more information, please contact:
Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com
About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.
Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Considering a portfolio review?
Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...
UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW
Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...
MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE
With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...
ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS
With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...
HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW
Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...
ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.
Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed
Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...
EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES
As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...
UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS
Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...